Gene Symbol | Gene ID | Gene Info |
---|---|---|
Pou3f4
|
ENSMUSG00000056854.3 | POU domain, class 3, transcription factor 4 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chrX_110814092_110814465 | Pou3f4 | 2 | 0.978513 | 0.90 | 3.9e-21 | Click! |
chrX_110814525_110815208 | Pou3f4 | 586 | 0.771795 | 0.90 | 1.5e-20 | Click! |
chrX_110816655_110816848 | Pou3f4 | 2471 | 0.334103 | 0.88 | 1.5e-18 | Click! |
chrX_110851519_110851679 | Pou3f4 | 37319 | 0.186083 | 0.83 | 2.6e-15 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr16_77236959_77237505 | 43.79 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
913 |
0.66 |
chr14_119857299_119857740 | 39.97 |
4930404K13Rik |
RIKEN cDNA 4930404K13 gene |
58541 |
0.13 |
chr5_77838512_77838806 | 38.47 |
Gm42673 |
predicted gene 42673 |
70801 |
0.12 |
chr14_14347096_14348750 | 37.05 |
Gm48860 |
predicted gene, 48860 |
659 |
0.44 |
chr15_70594450_70594601 | 34.66 |
Gm18155 |
predicted gene, 18155 |
163528 |
0.04 |
chr9_23062142_23062343 | 33.90 |
Bmper |
BMP-binding endothelial regulator |
160834 |
0.04 |
chr14_93067075_93067302 | 32.83 |
Gm23509 |
predicted gene, 23509 |
71001 |
0.12 |
chr18_46213235_46213386 | 32.80 |
Trim36 |
tripartite motif-containing 36 |
703 |
0.66 |
chr8_53600519_53600706 | 32.52 |
Neil3 |
nei like 3 (E. coli) |
9007 |
0.27 |
chr4_24429638_24429836 | 32.02 |
Gm27243 |
predicted gene 27243 |
1153 |
0.54 |
chr13_26657396_26657590 | 31.20 |
Gm47883 |
predicted gene, 47883 |
23200 |
0.23 |
chr7_16134906_16135134 | 30.89 |
Slc8a2 |
solute carrier family 8 (sodium/calcium exchanger), member 2 |
4672 |
0.13 |
chr10_92555827_92556000 | 30.62 |
Gm4800 |
predicted gene 4800 |
12243 |
0.16 |
chr15_44706767_44707004 | 29.28 |
Sybu |
syntabulin (syntaxin-interacting) |
40903 |
0.15 |
chr1_165934961_165935308 | 28.32 |
Pou2f1 |
POU domain, class 2, transcription factor 1 |
123 |
0.95 |
chr10_69744304_69744513 | 27.78 |
Ank3 |
ankyrin 3, epithelial |
37930 |
0.22 |
chr3_21891883_21892491 | 27.57 |
7530428D23Rik |
RIKEN cDNA 7530428D23 gene |
91414 |
0.08 |
chr4_22301242_22301470 | 27.47 |
Gm11882 |
predicted gene 11882 |
25523 |
0.2 |
chr13_84566286_84566489 | 27.43 |
Gm26913 |
predicted gene, 26913 |
124554 |
0.06 |
chr14_118230432_118230634 | 26.74 |
Gm4675 |
predicted gene 4675 |
5699 |
0.14 |
chr2_123364225_123364551 | 26.70 |
Gm13988 |
predicted gene 13988 |
90464 |
0.1 |
chr4_39345030_39345334 | 26.57 |
Gm23607 |
predicted gene, 23607 |
49719 |
0.14 |
chr18_25525761_25525937 | 26.29 |
Celf4 |
CUGBP, Elav-like family member 4 |
24610 |
0.23 |
chr6_135112396_135112681 | 26.07 |
Gprc5d |
G protein-coupled receptor, family C, group 5, member D |
5708 |
0.14 |
chr11_41532495_41533004 | 25.99 |
Hspd1-ps3 |
heat shock protein 1 (chaperonin), pseudogene 3 |
34012 |
0.2 |
chr15_25761802_25762209 | 25.70 |
Myo10 |
myosin X |
3220 |
0.3 |
chr15_73886936_73887266 | 25.66 |
Mroh5 |
maestro heat-like repeat family member 5 |
47402 |
0.13 |
chr10_52577862_52578221 | 25.63 |
Gm36065 |
predicted gene, 36065 |
15971 |
0.14 |
chr13_84905713_84906063 | 25.57 |
Gm4059 |
predicted gene 4059 |
68429 |
0.12 |
chr6_32796194_32796358 | 25.53 |
Chchd3 |
coiled-coil-helix-coiled-coil-helix domain containing 3 |
7716 |
0.27 |
chr5_32278343_32278541 | 25.38 |
Plb1 |
phospholipase B1 |
31091 |
0.13 |
chr13_85066695_85066901 | 25.30 |
Gm47745 |
predicted gene, 47745 |
27537 |
0.17 |
chr7_58787065_58787260 | 25.21 |
Gm6226 |
predicted gene 6226 |
50776 |
0.11 |
chr6_140962609_140962796 | 25.14 |
Gm30524 |
predicted gene, 30524 |
7067 |
0.26 |
chr8_30648481_30648881 | 24.94 |
4933433F19Rik |
RIKEN cDNA 4933433F19 gene |
80288 |
0.11 |
chr13_23949732_23949947 | 24.87 |
Scgn |
secretagogin, EF-hand calcium binding protein |
5740 |
0.1 |
chr19_14777197_14777401 | 24.78 |
Gm26026 |
predicted gene, 26026 |
58819 |
0.15 |
chr7_3410706_3410863 | 24.73 |
Gm23450 |
predicted gene, 23450 |
4282 |
0.1 |
chr4_71229701_71230138 | 24.53 |
Gm11229 |
predicted gene 11229 |
56023 |
0.15 |
chr14_60410314_60410651 | 24.50 |
Gm6066 |
predicted gene 6066 |
31497 |
0.16 |
chr4_31728123_31728423 | 24.49 |
Map3k7 |
mitogen-activated protein kinase kinase kinase 7 |
235824 |
0.02 |
chr7_76185386_76185573 | 24.36 |
Agbl1 |
ATP/GTP binding protein-like 1 |
44408 |
0.17 |
chr1_13936038_13936249 | 24.32 |
Gm36947 |
predicted gene, 36947 |
87024 |
0.09 |
chr3_69373662_69373828 | 24.22 |
Gm17212 |
predicted gene 17212 |
37985 |
0.14 |
chrX_22850177_22850580 | 24.15 |
Gm26131 |
predicted gene, 26131 |
11558 |
0.32 |
chr18_5228017_5228168 | 24.13 |
Gm26682 |
predicted gene, 26682 |
62361 |
0.12 |
chr14_38825108_38825292 | 24.11 |
Nrg3os |
neuregulin 3, opposite strand |
73102 |
0.12 |
chr19_15340816_15341006 | 23.88 |
Gm24319 |
predicted gene, 24319 |
339093 |
0.01 |
chr15_30457525_30457710 | 23.86 |
Ctnnd2 |
catenin (cadherin associated protein), delta 2 |
56 |
0.98 |
chr13_110115255_110115618 | 23.84 |
Rab3c |
RAB3C, member RAS oncogene family |
164714 |
0.04 |
chr1_66323589_66323774 | 23.71 |
Map2 |
microtubule-associated protein 2 |
1579 |
0.37 |
chr7_51748719_51749329 | 23.56 |
Gm7336 |
predicted gene 7336 |
2377 |
0.28 |
chr13_75090221_75090438 | 23.55 |
Pcsk1 |
proprotein convertase subtilisin/kexin type 1 |
413 |
0.9 |
chr12_89817220_89817371 | 23.17 |
Nrxn3 |
neurexin III |
4812 |
0.35 |
chr15_72852182_72852611 | 23.13 |
Peg13 |
paternally expressed 13 |
42072 |
0.16 |
chr8_6456893_6457222 | 23.08 |
Gm44844 |
predicted gene 44844 |
19313 |
0.29 |
chr13_78200366_78200817 | 22.95 |
A830082K12Rik |
RIKEN cDNA A830082K12 gene |
813 |
0.37 |
chr14_12393119_12393544 | 22.91 |
Gm48267 |
predicted gene, 48267 |
8899 |
0.14 |
chr17_90087882_90088033 | 22.81 |
Nrxn1 |
neurexin I |
183 |
0.97 |
chr11_78786013_78786424 | 22.78 |
Gm23840 |
predicted gene, 23840 |
31696 |
0.11 |
chr5_32713265_32714499 | 22.60 |
Gm43852 |
predicted gene 43852 |
106 |
0.94 |
chr3_55966031_55966182 | 22.37 |
Nbea |
neurobeachin |
2130 |
0.31 |
chr12_5215893_5216095 | 22.36 |
Gm48532 |
predicted gene, 48532 |
19970 |
0.23 |
chr4_102187015_102187166 | 22.34 |
Pde4b |
phosphodiesterase 4B, cAMP specific |
67652 |
0.12 |
chr9_41697271_41698297 | 22.27 |
Gm48784 |
predicted gene, 48784 |
22730 |
0.14 |
chr5_24019464_24019661 | 21.99 |
Gm6745 |
predicted gene 6745 |
9150 |
0.15 |
chr3_105004277_105004472 | 21.92 |
Gm40117 |
predicted gene, 40117 |
10342 |
0.16 |
chr4_5963296_5963573 | 21.91 |
Gm11797 |
predicted gene 11797 |
106440 |
0.07 |
chr8_33747700_33747868 | 21.88 |
Smim18 |
small integral membrane protein 18 |
14 |
0.97 |
chr11_37936852_37937003 | 21.85 |
Gm25693 |
predicted gene, 25693 |
100336 |
0.09 |
chr16_66969715_66969926 | 21.82 |
Cadm2 |
cell adhesion molecule 2 |
16486 |
0.28 |
chr16_73108327_73108499 | 21.75 |
4930500H12Rik |
RIKEN cDNA 4930500H12 gene |
9425 |
0.31 |
chr15_18821156_18821696 | 21.71 |
Cdh10 |
cadherin 10 |
1097 |
0.54 |
chr16_77236189_77236366 | 21.69 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
40 |
0.98 |
chr12_49945819_49946221 | 21.65 |
Gm7481 |
predicted gene 7481 |
104269 |
0.08 |
chr4_45819207_45819704 | 21.60 |
Igfbpl1 |
insulin-like growth factor binding protein-like 1 |
3092 |
0.2 |
chr4_20317105_20317256 | 21.45 |
Gm11872 |
predicted gene 11872 |
26526 |
0.24 |
chr6_52119364_52119515 | 21.38 |
Rps8-ps3 |
ribosomal protein S8, pseudogene 3 |
1197 |
0.26 |
chr2_63963866_63964056 | 21.37 |
Fign |
fidgetin |
134027 |
0.06 |
chr9_55083363_55083565 | 21.36 |
Gm7395 |
predicted gene 7395 |
11906 |
0.13 |
chr13_69260577_69260855 | 21.35 |
Gm4812 |
predicted gene 4812 |
84939 |
0.08 |
chr13_58964694_58965094 | 21.27 |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
93159 |
0.06 |
chr14_66319931_66320237 | 21.26 |
Gm41183 |
predicted gene, 41183 |
21145 |
0.13 |
chr18_81166272_81166423 | 21.26 |
4930594M17Rik |
RIKEN cDNA 4930594M17 gene |
69719 |
0.09 |
chr12_29095988_29096385 | 21.22 |
4833405L11Rik |
RIKEN cDNA 4833405L11 gene |
10551 |
0.23 |
chr15_40533683_40533834 | 21.14 |
Gm7382 |
predicted gene 7382 |
3563 |
0.28 |
chr2_63963076_63963322 | 21.02 |
Fign |
fidgetin |
134789 |
0.06 |
chr12_65216661_65216843 | 21.02 |
Gm31063 |
predicted gene, 31063 |
3251 |
0.19 |
chr3_88222179_88222410 | 20.99 |
Gm3764 |
predicted gene 3764 |
370 |
0.69 |
chr3_119154673_119154893 | 20.99 |
Gm43410 |
predicted gene 43410 |
286539 |
0.01 |
chr4_124048547_124048762 | 20.98 |
Gm12902 |
predicted gene 12902 |
122420 |
0.04 |
chr4_85763241_85763411 | 20.97 |
Adamtsl1 |
ADAMTS-like 1 |
248999 |
0.02 |
chr2_75246495_75246656 | 20.82 |
2600014E21Rik |
RIKEN cDNA 2600014E21 gene |
1825 |
0.34 |
chr13_28420360_28420511 | 20.75 |
Gm40841 |
predicted gene, 40841 |
369 |
0.9 |
chr3_66326335_66326732 | 20.64 |
Veph1 |
ventricular zone expressed PH domain-containing 1 |
29696 |
0.18 |
chr5_149488554_149488977 | 20.60 |
Gm2566 |
predicted gene 2566 |
14287 |
0.12 |
chr15_25019454_25019630 | 20.50 |
Gm2824 |
predicted gene 2824 |
1148 |
0.6 |
chr9_120869370_120869765 | 20.50 |
Gm34425 |
predicted gene, 34425 |
379 |
0.68 |
chr16_67610911_67611282 | 20.38 |
Cadm2 |
cell adhesion molecule 2 |
9397 |
0.25 |
chr10_26827294_26827613 | 20.36 |
Arhgap18 |
Rho GTPase activating protein 18 |
4851 |
0.26 |
chr8_124386596_124386768 | 20.30 |
Pgbd5 |
piggyBac transposable element derived 5 |
6534 |
0.19 |
chr18_29267767_29267918 | 20.27 |
Gm34743 |
predicted gene, 34743 |
22495 |
0.28 |
chr3_5347552_5347820 | 20.25 |
Zfhx4 |
zinc finger homeodomain 4 |
106014 |
0.07 |
chr4_23341271_23341551 | 20.20 |
Gm11884 |
predicted gene 11884 |
80627 |
0.11 |
chr6_58932915_58933165 | 20.15 |
Herc3 |
hect domain and RLD 3 |
25778 |
0.12 |
chr5_5134242_5134421 | 20.09 |
Gm43623 |
predicted gene 43623 |
5776 |
0.2 |
chr15_92161110_92161283 | 20.09 |
Cntn1 |
contactin 1 |
161 |
0.97 |
chr18_88040235_88040423 | 19.91 |
Gm50391 |
predicted gene, 50391 |
56221 |
0.16 |
chr3_156560293_156560473 | 19.90 |
4930570G19Rik |
RIKEN cDNA 4930570G19 gene |
1199 |
0.41 |
chr17_69769280_69769433 | 19.90 |
Gm49895 |
predicted gene, 49895 |
6656 |
0.3 |
chr12_27139384_27139553 | 19.79 |
Gm9866 |
predicted gene 9866 |
20843 |
0.27 |
chr17_93260660_93261401 | 19.76 |
Gm25935 |
predicted gene, 25935 |
14216 |
0.19 |
chr13_78937424_78937962 | 19.72 |
Gm8345 |
predicted gene 8345 |
17099 |
0.29 |
chr9_61509897_61510259 | 19.67 |
Gm34424 |
predicted gene, 34424 |
355 |
0.89 |
chr18_72033026_72033203 | 19.56 |
Dcc |
deleted in colorectal carcinoma |
317903 |
0.01 |
chr6_78245012_78245212 | 19.56 |
Gm5576 |
predicted pseudogene 5576 |
29234 |
0.21 |
chr12_35008430_35008636 | 19.55 |
Prps1l1 |
phosphoribosyl pyrophosphate synthetase 1-like 1 |
23772 |
0.17 |
chr2_28296168_28296542 | 19.55 |
Gm13373 |
predicted gene 13373 |
27695 |
0.19 |
chr1_35957784_35957967 | 19.54 |
Gm8022 |
predicted gene 8022 |
1044 |
0.49 |
chr14_103763329_103763480 | 19.41 |
Slain1os |
SLAIN motif family, member 1, opposite strand |
63962 |
0.11 |
chr6_6869733_6869901 | 19.41 |
Dlx6os1 |
distal-less homeobox 6, opposite strand 1 |
1775 |
0.24 |
chr18_46066421_46066635 | 19.40 |
A330093E20Rik |
RIKEN cDNA A330093E20 gene |
21268 |
0.2 |
chr5_35454198_35454812 | 19.31 |
Gm43377 |
predicted gene 43377 |
58407 |
0.08 |
chr19_23388976_23389167 | 19.30 |
Gm50445 |
predicted gene, 50445 |
29272 |
0.16 |
chr9_42179185_42179358 | 19.29 |
4930546K05Rik |
RIKEN cDNA 4930546K05 gene |
29942 |
0.15 |
chr9_78880685_78880932 | 19.28 |
Gm47498 |
predicted gene, 47498 |
55975 |
0.11 |
chr14_117895288_117895467 | 19.27 |
Mir6239 |
microRNA 6239 |
58470 |
0.14 |
chr13_104518786_104518997 | 19.21 |
2610204G07Rik |
RIKEN cDNA 2610204G07 gene |
166040 |
0.03 |
chr4_96968887_96969075 | 19.17 |
Gm27521 |
predicted gene, 27521 |
51961 |
0.15 |
chr5_111660947_111661098 | 19.14 |
Gm42489 |
predicted gene 42489 |
67406 |
0.09 |
chr6_22984216_22984575 | 19.07 |
Ptprz1 |
protein tyrosine phosphatase, receptor type Z, polypeptide 1 |
1914 |
0.44 |
chr5_107497460_107497812 | 19.05 |
Btbd8 |
BTB (POZ) domain containing 8 |
140 |
0.93 |
chr7_137250453_137250635 | 19.02 |
Gm10578 |
predicted gene 10578 |
15861 |
0.18 |
chr13_75992746_75992897 | 18.91 |
Spata9 |
spermatogenesis associated 9 |
25074 |
0.1 |
chr13_16645409_16645619 | 18.91 |
Gm7537 |
predicted gene 7537 |
6024 |
0.31 |
chr8_98365807_98365981 | 18.88 |
Gm7192 |
predicted gene 7192 |
141231 |
0.05 |
chr2_76556286_76556445 | 18.87 |
Osbpl6 |
oxysterol binding protein-like 6 |
8025 |
0.23 |
chr12_27082382_27083027 | 18.80 |
Gm9866 |
predicted gene 9866 |
32291 |
0.24 |
chr5_62813834_62814023 | 18.77 |
Dthd1 |
death domain containing 1 |
105 |
0.98 |
chr7_122478149_122478324 | 18.77 |
Gm14389 |
predicted gene 14389 |
6184 |
0.17 |
chr3_34659334_34659485 | 18.68 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
3373 |
0.14 |
chrX_69580206_69580357 | 18.67 |
Gm8172 |
predicted pseudogene 8172 |
25964 |
0.26 |
chr2_96401290_96401481 | 18.63 |
Lrrc4c |
leucine rich repeat containing 4C |
83169 |
0.11 |
chr18_25377822_25377990 | 18.58 |
Gm16558 |
predicted gene 16558 |
13895 |
0.27 |
chr6_119319140_119319302 | 18.57 |
Lrtm2 |
leucine-rich repeats and transmembrane domains 2 |
9983 |
0.2 |
chr3_26330975_26331149 | 18.55 |
A830092H15Rik |
RIKEN cDNA A830092H15 gene |
88 |
0.94 |
chr17_9775695_9776189 | 18.53 |
4930452A19Rik |
RIKEN cDNA 4930452A19 gene |
75 |
0.98 |
chr5_131775416_131775620 | 18.50 |
Gm42442 |
predicted gene 42442 |
77165 |
0.07 |
chr7_76392345_76392603 | 18.43 |
Agbl1 |
ATP/GTP binding protein-like 1 |
18588 |
0.28 |
chr1_42693847_42694189 | 18.43 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
790 |
0.32 |
chr18_46112843_46113169 | 18.42 |
Gm38337 |
predicted gene, 38337 |
253 |
0.94 |
chr10_37779526_37779677 | 18.39 |
Gm24710 |
predicted gene, 24710 |
152079 |
0.04 |
chr15_40114597_40115428 | 18.37 |
9330182O14Rik |
RIKEN cDNA 9330182O14 gene |
19353 |
0.17 |
chr13_89339351_89339502 | 18.35 |
Hapln1 |
hyaluronan and proteoglycan link protein 1 |
200370 |
0.03 |
chr14_71963922_71964073 | 18.35 |
4930434J06Rik |
RIKEN cDNA 4930434J06 gene |
50906 |
0.18 |
chr1_74858050_74858726 | 18.25 |
Cdk5r2 |
cyclin-dependent kinase 5, regulatory subunit 2 (p39) |
3454 |
0.13 |
chr10_118959749_118959913 | 18.23 |
Gm38403 |
predicted gene, 38403 |
32688 |
0.13 |
chr10_16053290_16053544 | 18.21 |
C330004P14Rik |
RIKEN cDNA C330004P14 gene |
261640 |
0.02 |
chr3_141197376_141197568 | 18.19 |
Pdha2 |
pyruvate dehydrogenase E1 alpha 2 |
14883 |
0.29 |
chr14_74113188_74113446 | 18.16 |
Gm49170 |
predicted gene, 49170 |
139091 |
0.04 |
chr12_65382458_65382659 | 18.14 |
Gm26015 |
predicted gene, 26015 |
23412 |
0.22 |
chr3_127705467_127706232 | 18.14 |
1500005C15Rik |
RIKEN cDNA 1500005C15 gene |
11178 |
0.11 |
chr12_112542537_112542889 | 18.13 |
Tmem179 |
transmembrane protein 179 |
25966 |
0.13 |
chr1_162410707_162410867 | 18.10 |
Dnm3 |
dynamin 3 |
3452 |
0.29 |
chr4_71840127_71840324 | 18.07 |
Gm11233 |
predicted gene 11233 |
27763 |
0.23 |
chr8_40633457_40633627 | 18.02 |
Mtmr7 |
myotubularin related protein 7 |
1217 |
0.44 |
chr1_34665096_34665536 | 17.83 |
Arhgef4 |
Rho guanine nucleotide exchange factor (GEF) 4 |
12872 |
0.12 |
chr11_104106366_104106692 | 17.83 |
Crhr1 |
corticotropin releasing hormone receptor 1 |
26326 |
0.19 |
chr10_20945013_20945164 | 17.78 |
Ahi1 |
Abelson helper integration site 1 |
7459 |
0.23 |
chr6_61099697_61099880 | 17.78 |
Gm43893 |
predicted gene, 43893 |
30533 |
0.15 |
chr7_40825372_40825735 | 17.77 |
Gm45008 |
predicted gene 45008 |
4443 |
0.2 |
chr5_39772042_39772399 | 17.65 |
Hs3st1 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 1 |
16745 |
0.22 |
chr14_60086355_60087362 | 17.64 |
Atp8a2 |
ATPase, aminophospholipid transporter-like, class I, type 8A, member 2 |
24 |
0.73 |
chr3_38913293_38913472 | 17.60 |
Fat4 |
FAT atypical cadherin 4 |
22440 |
0.2 |
chrX_75673394_75674325 | 17.59 |
Gm15065 |
predicted gene 15065 |
31550 |
0.13 |
chr4_56179000_56179174 | 17.49 |
Gm12520 |
predicted gene 12520 |
16147 |
0.25 |
chr3_41408793_41409655 | 17.48 |
Gm25487 |
predicted gene, 25487 |
32243 |
0.14 |
chr8_66910761_66911024 | 17.47 |
Gm39185 |
predicted gene, 39185 |
4895 |
0.21 |
chr13_78183094_78183418 | 17.38 |
Gm38604 |
predicted gene, 38604 |
88 |
0.96 |
chr7_51215898_51216185 | 17.32 |
Gm16478 |
predicted pseudogene 16478 |
45524 |
0.16 |
chr1_164988310_164988493 | 17.25 |
1700029M03Rik |
RIKEN cDNA 1700029M03 gene |
27478 |
0.14 |
chr9_73681080_73681313 | 17.23 |
Gm27148 |
predicted gene 27148 |
4504 |
0.32 |
chr18_17768254_17768490 | 17.21 |
Gm50083 |
predicted gene, 50083 |
60447 |
0.15 |
chr15_92743865_92744028 | 17.12 |
Pdzrn4 |
PDZ domain containing RING finger 4 |
303 |
0.93 |
chr3_156526453_156526604 | 17.06 |
4930570G19Rik |
RIKEN cDNA 4930570G19 gene |
35054 |
0.17 |
chr9_49606490_49606655 | 17.06 |
Ncam1 |
neural cell adhesion molecule 1 |
38023 |
0.19 |
chrX_157307133_157307284 | 17.04 |
Gm25795 |
predicted gene, 25795 |
7587 |
0.23 |
chr4_12307295_12307478 | 17.03 |
Gm11846 |
predicted gene 11846 |
35987 |
0.18 |
chr15_86419577_86420037 | 16.99 |
A930001M01Rik |
RIKEN cDNA A930001M01 gene |
55288 |
0.15 |
chr13_29015223_29015589 | 16.88 |
A330102I10Rik |
RIKEN cDNA A330102I10 gene |
887 |
0.68 |
chr16_72610904_72611128 | 16.86 |
Robo1 |
roundabout guidance receptor 1 |
47316 |
0.2 |
chrX_105391243_105391597 | 16.80 |
5330434G04Rik |
RIKEN cDNA 5330434G04 gene |
334 |
0.87 |
chr10_66271002_66271188 | 16.73 |
1700023F02Rik |
RIKEN cDNA 1700023F02 gene |
16872 |
0.26 |
chr3_88228408_88228559 | 16.73 |
Gm3764 |
predicted gene 3764 |
85 |
0.92 |
chr5_70842284_70842796 | 16.73 |
Gabrg1 |
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 1 |
77 |
0.99 |
chr6_112524619_112524770 | 16.71 |
Gm27944 |
predicted gene, 27944 |
11247 |
0.16 |
chr13_84404617_84405068 | 16.68 |
Gm26927 |
predicted gene, 26927 |
64729 |
0.12 |
chr15_53902158_53902619 | 16.65 |
Samd12 |
sterile alpha motif domain containing 12 |
7 |
0.98 |
chr17_80969670_80969950 | 16.57 |
Tmem178 |
transmembrane protein 178 |
25178 |
0.19 |
chr12_45598321_45598472 | 16.56 |
Gm48517 |
predicted gene, 48517 |
25109 |
0.23 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.6 | 40.7 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
9.7 | 29.1 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
5.8 | 17.3 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
5.1 | 35.9 | GO:0042118 | endothelial cell activation(GO:0042118) |
5.1 | 20.4 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
4.7 | 14.2 | GO:0072025 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
4.6 | 13.9 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
4.4 | 4.4 | GO:1902988 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
4.4 | 13.1 | GO:0046684 | response to pyrethroid(GO:0046684) |
4.4 | 26.2 | GO:0042297 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
4.0 | 12.1 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
4.0 | 15.8 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
3.8 | 11.3 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
3.8 | 7.6 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
3.7 | 11.2 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
3.6 | 10.9 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
3.5 | 10.6 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
3.3 | 13.3 | GO:0001927 | exocyst assembly(GO:0001927) |
3.1 | 9.2 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
3.0 | 14.9 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
2.9 | 8.8 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
2.9 | 8.6 | GO:1990034 | calcium ion export from cell(GO:1990034) |
2.9 | 11.5 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
2.8 | 8.5 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
2.7 | 2.7 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
2.6 | 7.8 | GO:0071873 | response to norepinephrine(GO:0071873) |
2.6 | 7.7 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
2.5 | 4.9 | GO:0046865 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
2.4 | 19.6 | GO:0050957 | equilibrioception(GO:0050957) |
2.4 | 14.4 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
2.4 | 4.8 | GO:0045608 | negative regulation of auditory receptor cell differentiation(GO:0045608) |
2.3 | 11.6 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
2.3 | 9.3 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
2.2 | 2.2 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
2.2 | 4.4 | GO:0031223 | auditory behavior(GO:0031223) |
2.2 | 13.3 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
2.2 | 4.3 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
2.2 | 6.5 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
2.1 | 16.8 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
2.1 | 8.3 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
2.0 | 10.2 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
2.0 | 8.0 | GO:0030035 | microspike assembly(GO:0030035) |
2.0 | 7.9 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
1.9 | 7.7 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
1.9 | 5.8 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
1.9 | 9.5 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
1.8 | 3.7 | GO:0016198 | axon choice point recognition(GO:0016198) |
1.8 | 27.3 | GO:0016486 | peptide hormone processing(GO:0016486) |
1.8 | 1.8 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
1.8 | 3.6 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
1.8 | 8.8 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
1.8 | 14.1 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
1.8 | 5.3 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
1.7 | 7.0 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
1.7 | 1.7 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
1.7 | 5.2 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
1.7 | 6.9 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
1.7 | 5.1 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
1.7 | 3.4 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
1.7 | 1.7 | GO:0035483 | gastric emptying(GO:0035483) |
1.7 | 6.7 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
1.7 | 3.3 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
1.6 | 4.9 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
1.6 | 11.3 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
1.6 | 6.5 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
1.6 | 4.8 | GO:0023041 | neuronal signal transduction(GO:0023041) |
1.6 | 8.0 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
1.6 | 10.9 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
1.5 | 1.5 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
1.5 | 9.1 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
1.5 | 16.5 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
1.5 | 7.4 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
1.5 | 4.4 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
1.5 | 4.4 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
1.4 | 31.1 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
1.4 | 2.8 | GO:0035905 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
1.4 | 1.4 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
1.4 | 1.4 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
1.4 | 4.1 | GO:0089700 | protein kinase D signaling(GO:0089700) |
1.4 | 2.7 | GO:0021586 | pons maturation(GO:0021586) |
1.3 | 2.7 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
1.3 | 7.9 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
1.3 | 5.3 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
1.3 | 5.1 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
1.3 | 5.0 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
1.3 | 2.5 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
1.3 | 10.0 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
1.2 | 12.3 | GO:0060134 | prepulse inhibition(GO:0060134) |
1.2 | 3.7 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
1.2 | 2.4 | GO:0060166 | olfactory pit development(GO:0060166) |
1.2 | 2.4 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
1.2 | 3.6 | GO:0060005 | vestibular reflex(GO:0060005) |
1.2 | 2.4 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
1.2 | 5.8 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
1.1 | 2.3 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
1.1 | 5.6 | GO:0070995 | NADPH oxidation(GO:0070995) |
1.1 | 3.3 | GO:0015889 | cobalamin transport(GO:0015889) |
1.1 | 5.5 | GO:0021855 | hypothalamus cell migration(GO:0021855) |
1.1 | 90.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
1.1 | 2.1 | GO:0060594 | mammary gland specification(GO:0060594) |
1.1 | 2.1 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
1.1 | 10.6 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
1.1 | 5.3 | GO:0080009 | mRNA methylation(GO:0080009) |
1.0 | 3.1 | GO:0031296 | B cell costimulation(GO:0031296) |
1.0 | 21.8 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
1.0 | 3.1 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
1.0 | 1.0 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
1.0 | 5.1 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
1.0 | 3.0 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
1.0 | 2.0 | GO:0035262 | gonad morphogenesis(GO:0035262) |
1.0 | 3.0 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
1.0 | 2.0 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
1.0 | 4.9 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
1.0 | 2.9 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
1.0 | 1.9 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
1.0 | 1.0 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.9 | 2.8 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.9 | 7.4 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.9 | 2.8 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.9 | 2.8 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.9 | 6.4 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.9 | 3.6 | GO:0071625 | vocalization behavior(GO:0071625) |
0.9 | 3.6 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.9 | 1.8 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.9 | 2.7 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.9 | 1.8 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.9 | 15.1 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.9 | 2.7 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.9 | 8.0 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.9 | 3.5 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.9 | 12.2 | GO:0061162 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.9 | 6.0 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.9 | 2.6 | GO:2000437 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
0.9 | 29.9 | GO:0019228 | neuronal action potential(GO:0019228) |
0.9 | 0.9 | GO:0048371 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
0.9 | 3.4 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.8 | 4.2 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.8 | 9.3 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.8 | 4.2 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.8 | 27.5 | GO:0007340 | acrosome reaction(GO:0007340) |
0.8 | 2.5 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.8 | 10.0 | GO:0022038 | corpus callosum development(GO:0022038) |
0.8 | 2.5 | GO:0046959 | habituation(GO:0046959) |
0.8 | 5.8 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.8 | 2.5 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.8 | 1.6 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.8 | 39.8 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.8 | 1.6 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.8 | 8.9 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.8 | 3.2 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.8 | 8.1 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.8 | 2.4 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.8 | 2.4 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.8 | 7.2 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.8 | 3.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.8 | 2.4 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.8 | 2.4 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.8 | 2.4 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.8 | 10.9 | GO:0034389 | lipid particle organization(GO:0034389) |
0.8 | 4.7 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.8 | 1.5 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.8 | 7.7 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.8 | 2.3 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.8 | 0.8 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.8 | 1.5 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.8 | 0.8 | GO:0007412 | axon target recognition(GO:0007412) |
0.8 | 3.0 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.8 | 8.3 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.7 | 2.2 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.7 | 0.7 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.7 | 2.2 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.7 | 1.4 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.7 | 2.2 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.7 | 9.8 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.7 | 2.1 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.7 | 4.1 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.7 | 1.4 | GO:0060423 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
0.7 | 3.4 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.7 | 0.7 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.7 | 1.4 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.7 | 1.4 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.7 | 0.7 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.7 | 1.3 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.7 | 2.0 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.7 | 2.0 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
0.7 | 2.7 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.7 | 2.0 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.7 | 1.3 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.7 | 1.3 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.7 | 6.6 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.7 | 1.3 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.7 | 0.7 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.7 | 2.0 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.7 | 6.5 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.6 | 1.3 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.6 | 1.9 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.6 | 18.4 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.6 | 1.9 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.6 | 2.5 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.6 | 1.2 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.6 | 1.8 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.6 | 1.8 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.6 | 1.2 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.6 | 7.8 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.6 | 1.2 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.6 | 1.8 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.6 | 2.4 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.6 | 7.7 | GO:0042407 | cristae formation(GO:0042407) |
0.6 | 1.2 | GO:0072162 | metanephric mesenchymal cell differentiation(GO:0072162) |
0.6 | 3.0 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.6 | 1.8 | GO:0033153 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.6 | 1.8 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.6 | 1.8 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.6 | 1.2 | GO:0051944 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.6 | 4.7 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.6 | 2.3 | GO:0030091 | protein repair(GO:0030091) |
0.6 | 2.3 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.6 | 0.6 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.6 | 2.3 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.6 | 6.8 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.6 | 4.0 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
0.6 | 0.6 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.6 | 1.7 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.6 | 1.7 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.6 | 1.7 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.6 | 1.7 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
0.6 | 1.7 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.5 | 3.8 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.5 | 2.2 | GO:0021955 | central nervous system neuron axonogenesis(GO:0021955) |
0.5 | 4.3 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.5 | 2.7 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.5 | 0.5 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.5 | 4.8 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.5 | 3.2 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.5 | 0.5 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.5 | 0.5 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.5 | 1.6 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.5 | 1.1 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.5 | 0.5 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.5 | 1.1 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.5 | 0.5 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.5 | 1.0 | GO:0036394 | amylase secretion(GO:0036394) |
0.5 | 1.6 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.5 | 0.5 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.5 | 1.5 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.5 | 2.6 | GO:0048840 | otolith development(GO:0048840) |
0.5 | 1.0 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.5 | 1.5 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.5 | 10.2 | GO:0007616 | long-term memory(GO:0007616) |
0.5 | 2.0 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.5 | 1.0 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.5 | 5.5 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.5 | 1.5 | GO:0072530 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.5 | 0.5 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.5 | 1.5 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.5 | 1.5 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.5 | 4.4 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.5 | 2.0 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.5 | 2.5 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.5 | 2.4 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.5 | 2.0 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.5 | 5.4 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.5 | 4.3 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.5 | 1.4 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.5 | 0.5 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.5 | 3.7 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.5 | 1.4 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
0.5 | 1.4 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.5 | 2.3 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.5 | 1.8 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.5 | 1.4 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.5 | 0.9 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.4 | 9.9 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.4 | 0.9 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.4 | 1.8 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.4 | 4.5 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.4 | 1.8 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.4 | 0.9 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.4 | 1.3 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.4 | 8.8 | GO:0002090 | regulation of receptor internalization(GO:0002090) |
0.4 | 0.4 | GO:0006848 | pyruvate transport(GO:0006848) |
0.4 | 2.2 | GO:0051590 | positive regulation of neurotransmitter transport(GO:0051590) |
0.4 | 1.3 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.4 | 0.9 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.4 | 0.4 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.4 | 1.7 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.4 | 0.9 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.4 | 0.9 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.4 | 3.0 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.4 | 3.4 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.4 | 1.3 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.4 | 0.4 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.4 | 2.1 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
0.4 | 1.7 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.4 | 1.2 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.4 | 1.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.4 | 2.9 | GO:1902221 | L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
0.4 | 0.4 | GO:0014056 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) |
0.4 | 0.4 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.4 | 0.4 | GO:0042706 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.4 | 1.2 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.4 | 1.6 | GO:0071435 | potassium ion export(GO:0071435) |
0.4 | 1.6 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.4 | 0.8 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.4 | 3.6 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.4 | 0.8 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.4 | 1.6 | GO:0051697 | protein delipidation(GO:0051697) |
0.4 | 1.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.4 | 1.5 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.4 | 1.5 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.4 | 0.8 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.4 | 0.4 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.4 | 0.8 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.4 | 1.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.4 | 2.6 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.4 | 1.9 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.4 | 0.7 | GO:0060174 | limb bud formation(GO:0060174) |
0.4 | 2.2 | GO:0043482 | cellular pigment accumulation(GO:0043482) |
0.4 | 1.5 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.4 | 1.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.4 | 0.4 | GO:0052055 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) modulation by symbiont of host molecular function(GO:0052055) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) |
0.4 | 2.5 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.4 | 0.7 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.4 | 1.4 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.3 | 1.0 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.3 | 1.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.3 | 0.3 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.3 | 1.7 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.3 | 2.1 | GO:0032308 | regulation of prostaglandin secretion(GO:0032306) positive regulation of prostaglandin secretion(GO:0032308) |
0.3 | 1.7 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.3 | 0.7 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.3 | 1.0 | GO:1903232 | melanosome assembly(GO:1903232) |
0.3 | 1.4 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.3 | 2.7 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.3 | 2.0 | GO:0060736 | prostate gland growth(GO:0060736) |
0.3 | 1.0 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.3 | 5.3 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.3 | 1.0 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.3 | 1.3 | GO:0032906 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.3 | 1.3 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.3 | 1.9 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.3 | 1.0 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.3 | 5.1 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.3 | 1.6 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.3 | 0.6 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.3 | 2.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.3 | 1.2 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.3 | 2.8 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.3 | 0.3 | GO:0035106 | operant conditioning(GO:0035106) |
0.3 | 0.9 | GO:1901077 | regulation of relaxation of muscle(GO:1901077) |
0.3 | 1.2 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.3 | 0.3 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
0.3 | 2.4 | GO:1904871 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.3 | 1.5 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.3 | 1.2 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.3 | 1.5 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.3 | 0.9 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.3 | 0.3 | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.3 | 2.3 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.3 | 0.3 | GO:0097090 | presynaptic membrane organization(GO:0097090) |
0.3 | 0.9 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.3 | 2.3 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.3 | 0.6 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.3 | 0.9 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.3 | 0.3 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.3 | 2.8 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.3 | 1.7 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.3 | 0.8 | GO:1902837 | amino acid import into cell(GO:1902837) |
0.3 | 0.3 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.3 | 0.3 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.3 | 1.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.3 | 0.8 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.3 | 0.8 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.3 | 4.1 | GO:0097576 | vacuole fusion(GO:0097576) |
0.3 | 1.9 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.3 | 0.5 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.3 | 0.5 | GO:0035246 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine N-methylation(GO:0035246) |
0.3 | 0.5 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.3 | 1.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.3 | 0.5 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.3 | 0.5 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.3 | 0.8 | GO:0002254 | kinin cascade(GO:0002254) |
0.3 | 0.5 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.3 | 2.6 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.3 | 0.8 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.3 | 1.0 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.3 | 3.4 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
0.3 | 0.3 | GO:0051589 | negative regulation of neurotransmitter transport(GO:0051589) |
0.3 | 5.1 | GO:0047496 | vesicle transport along microtubule(GO:0047496) |
0.3 | 1.0 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.3 | 0.5 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.3 | 0.8 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.3 | 1.0 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.3 | 1.5 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.3 | 1.8 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.2 | 2.2 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.2 | 0.2 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
0.2 | 1.0 | GO:0060179 | male mating behavior(GO:0060179) |
0.2 | 0.2 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.2 | 0.5 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.2 | 0.7 | GO:0016115 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.2 | 3.4 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.2 | 1.7 | GO:1904874 | regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
0.2 | 3.4 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
0.2 | 1.2 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.2 | 0.5 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.2 | 0.2 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.2 | 12.5 | GO:0007269 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
0.2 | 0.7 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.2 | 2.2 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.2 | 0.2 | GO:0061110 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
0.2 | 1.2 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.2 | 0.2 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.2 | 0.7 | GO:0014028 | notochord formation(GO:0014028) |
0.2 | 0.7 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.2 | 0.5 | GO:0010612 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
0.2 | 0.5 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.2 | 0.5 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.2 | 0.5 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.2 | 0.5 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.2 | 1.1 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.2 | 0.7 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.2 | 0.9 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.2 | 0.5 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.2 | 0.7 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.2 | 5.4 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.2 | 0.7 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.2 | 3.6 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.2 | 1.3 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.2 | 0.7 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.2 | 1.3 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.2 | 0.7 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.2 | 0.9 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
0.2 | 1.5 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.2 | 0.4 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
0.2 | 1.5 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.2 | 1.3 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.2 | 0.4 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.2 | 2.6 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.2 | 0.6 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.2 | 1.9 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.2 | 0.2 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.2 | 5.9 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.2 | 0.4 | GO:0060618 | nipple development(GO:0060618) |
0.2 | 0.4 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.2 | 0.2 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.2 | 0.6 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.2 | 1.3 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.2 | 0.2 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.2 | 0.2 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.2 | 0.2 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.2 | 2.7 | GO:0008347 | glial cell migration(GO:0008347) |
0.2 | 0.2 | GO:0090135 | actin filament branching(GO:0090135) |
0.2 | 0.4 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.2 | 0.6 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.2 | 1.0 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.2 | 2.0 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.2 | 1.4 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.2 | 0.6 | GO:0070268 | cornification(GO:0070268) |
0.2 | 0.4 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
0.2 | 1.2 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.2 | 1.0 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.2 | 0.4 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.2 | 0.8 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
0.2 | 0.6 | GO:0008228 | opsonization(GO:0008228) |
0.2 | 0.6 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.2 | 0.8 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 0.6 | GO:0060004 | reflex(GO:0060004) |
0.2 | 1.7 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
0.2 | 0.6 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.2 | 0.6 | GO:0007567 | parturition(GO:0007567) |
0.2 | 1.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.2 | 1.8 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.2 | 0.6 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.2 | 0.5 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.2 | 2.2 | GO:0098868 | bone growth(GO:0098868) |
0.2 | 1.3 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 0.5 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.2 | 0.7 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.2 | 0.2 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.2 | 0.2 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.2 | 0.5 | GO:0035590 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.2 | 0.4 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.2 | 0.9 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.2 | 3.2 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.2 | 0.2 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.2 | 1.6 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.2 | 0.3 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.2 | 0.3 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.2 | 1.2 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.2 | 0.2 | GO:0072539 | T-helper 17 cell differentiation(GO:0072539) |
0.2 | 0.7 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.2 | 0.5 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.2 | 0.7 | GO:0042504 | tyrosine phosphorylation of Stat4 protein(GO:0042504) regulation of tyrosine phosphorylation of Stat4 protein(GO:0042519) |
0.2 | 0.7 | GO:0051775 | response to redox state(GO:0051775) |
0.2 | 0.7 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.2 | 0.8 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 0.8 | GO:0016264 | gap junction assembly(GO:0016264) |
0.2 | 0.6 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.2 | 2.3 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 0.8 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.2 | 0.3 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.2 | 1.1 | GO:0014047 | glutamate secretion(GO:0014047) |
0.2 | 0.2 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.2 | 0.2 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.2 | 0.3 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.2 | 0.5 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.2 | 1.2 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.2 | 0.5 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.2 | 5.0 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.2 | 1.4 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.2 | 0.5 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.2 | 1.2 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.2 | 2.7 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.2 | 0.5 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.1 | 0.6 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.1 | 0.4 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.1 | 0.3 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.4 | GO:0046874 | quinolinate biosynthetic process(GO:0019805) quinolinate metabolic process(GO:0046874) |
0.1 | 0.6 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.6 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.1 | 1.0 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.3 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.1 | 0.1 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
0.1 | 0.3 | GO:0090148 | membrane fission(GO:0090148) |
0.1 | 0.6 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 0.3 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.7 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.1 | 1.2 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.1 | 0.3 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
0.1 | 5.2 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.1 | 0.5 | GO:0090102 | cochlea development(GO:0090102) |
0.1 | 3.1 | GO:0071242 | cellular response to ammonium ion(GO:0071242) |
0.1 | 1.2 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 0.8 | GO:0048665 | neuron fate specification(GO:0048665) |
0.1 | 0.7 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 0.1 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.1 | 0.1 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.1 | 0.5 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.1 | 0.1 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.1 | 0.5 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.1 | 0.5 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.1 | 0.3 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 0.4 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.1 | 0.5 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.1 | 0.3 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.1 | 0.8 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.1 | 0.6 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.1 | 0.3 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 0.4 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.1 | 1.3 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 0.2 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 0.7 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.5 | GO:2000544 | cell chemotaxis to fibroblast growth factor(GO:0035766) endothelial cell chemotaxis to fibroblast growth factor(GO:0035768) regulation of cell chemotaxis to fibroblast growth factor(GO:1904847) regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000544) |
0.1 | 0.4 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.1 | 0.2 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.1 | 0.2 | GO:0048664 | neuron fate determination(GO:0048664) |
0.1 | 0.1 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.1 | 0.6 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.1 | 1.9 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 0.6 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.1 | 0.1 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.1 | 0.2 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 0.6 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.8 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.1 | 0.2 | GO:0086066 | atrial cardiac muscle cell action potential(GO:0086014) atrial cardiac muscle cell to AV node cell signaling(GO:0086026) atrial cardiac muscle cell to AV node cell communication(GO:0086066) |
0.1 | 0.2 | GO:0030432 | peristalsis(GO:0030432) |
0.1 | 0.7 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.1 | 1.8 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.1 | 0.8 | GO:0001964 | startle response(GO:0001964) |
0.1 | 0.5 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 0.5 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.1 | 0.2 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.1 | 0.2 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.1 | 0.2 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.1 | 0.5 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.2 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 0.5 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.2 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.1 | 0.1 | GO:0071472 | cellular response to salt stress(GO:0071472) |
0.1 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 0.3 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.5 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.1 | 0.7 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.1 | 0.2 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.1 | 0.2 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.1 | 0.9 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 0.5 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 0.2 | GO:0070474 | positive regulation of uterine smooth muscle contraction(GO:0070474) |
0.1 | 0.3 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 0.1 | GO:0060460 | left lung morphogenesis(GO:0060460) |
0.1 | 0.1 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 0.1 | GO:0070487 | monocyte aggregation(GO:0070487) |
0.1 | 1.5 | GO:0046677 | response to antibiotic(GO:0046677) |
0.1 | 0.5 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.1 | 0.7 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.1 | 0.4 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.1 | 0.2 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 1.1 | GO:0033750 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.1 | 0.1 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.1 | 0.2 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.1 | 0.3 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.1 | 0.2 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.1 | 0.6 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 1.2 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.1 | 0.2 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) |
0.1 | 0.2 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.1 | 1.1 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.1 | 0.3 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.1 | 0.3 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.1 | 0.4 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 0.9 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
0.1 | 0.2 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.1 | 0.2 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 0.2 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.1 | GO:0010288 | response to lead ion(GO:0010288) |
0.1 | 0.2 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 0.1 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.1 | 0.2 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 0.4 | GO:0032438 | melanosome organization(GO:0032438) |
0.1 | 0.7 | GO:0015800 | acidic amino acid transport(GO:0015800) |
0.1 | 0.2 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.1 | 0.4 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.1 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.1 | 0.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 0.3 | GO:0016093 | polyprenol metabolic process(GO:0016093) |
0.1 | 0.5 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.1 | 0.1 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.1 | 0.1 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.1 | 0.1 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.1 | 0.1 | GO:0051665 | membrane raft localization(GO:0051665) |
0.1 | 0.1 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.1 | 0.4 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.1 | 0.1 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.1 | 0.8 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.1 | 0.4 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.1 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) microtubule anchoring at microtubule organizing center(GO:0072393) |
0.1 | 0.3 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 0.1 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.1 | 4.1 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.1 | 0.2 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 0.3 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.1 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.1 | 0.3 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.4 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.3 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.3 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.1 | 0.3 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.1 | 0.7 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.1 | 0.3 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.1 | 0.5 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.1 | 0.2 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 0.1 | GO:1904996 | positive regulation of leukocyte tethering or rolling(GO:1903238) positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.1 | 0.4 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
0.1 | 0.7 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.1 | 0.6 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.1 | 0.2 | GO:0070341 | fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) |
0.1 | 0.1 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.1 | 0.2 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.1 | 0.2 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.1 | 0.1 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.1 | 0.4 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.1 | 0.1 | GO:0006562 | proline catabolic process(GO:0006562) |
0.1 | 0.3 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 0.2 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.3 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.1 | 0.3 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.1 | 0.1 | GO:0099625 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
0.1 | 0.2 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 0.1 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.1 | 0.1 | GO:0015817 | histidine transport(GO:0015817) |
0.1 | 0.1 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.1 | 0.1 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.1 | 0.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.5 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 0.1 | GO:2000412 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.0 | 1.3 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.0 | 0.3 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.5 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.3 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.0 | 0.1 | GO:0060462 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
0.0 | 0.3 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.8 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) |
0.0 | 0.2 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.0 | 0.1 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.0 | 1.9 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.4 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.1 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.0 | 0.7 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.0 | 0.0 | GO:0031579 | membrane raft organization(GO:0031579) |
0.0 | 0.1 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.0 | 0.1 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.0 | 0.1 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.0 | 0.0 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.0 | 0.0 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.0 | 1.1 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.0 | 0.0 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.0 | 0.3 | GO:0051642 | centrosome localization(GO:0051642) |
0.0 | 0.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 0.0 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.0 | 0.0 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.0 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.0 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.0 | 0.0 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.0 | 0.2 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.0 | 0.1 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) |
0.0 | 0.3 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.0 | 0.0 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.0 | 0.5 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.1 | GO:0021554 | optic nerve development(GO:0021554) |
0.0 | 1.3 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.1 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.0 | 0.1 | GO:0070986 | left/right axis specification(GO:0070986) |
0.0 | 0.1 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.0 | 0.1 | GO:0061687 | detoxification of copper ion(GO:0010273) detoxification of inorganic compound(GO:0061687) stress response to copper ion(GO:1990169) |
0.0 | 0.0 | GO:0060399 | regulation of growth hormone receptor signaling pathway(GO:0060398) positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.0 | 0.0 | GO:0035425 | autocrine signaling(GO:0035425) |
0.0 | 0.0 | GO:0050711 | negative regulation of interleukin-1 secretion(GO:0050711) |
0.0 | 0.0 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.0 | 0.0 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.0 | 0.1 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.0 | 0.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.1 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 0.4 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.0 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.0 | 0.1 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.0 | 0.0 | GO:0002890 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
0.0 | 0.1 | GO:0052490 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.0 | 0.0 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.0 | 0.0 | GO:1904238 | pericyte cell differentiation(GO:1904238) |
0.0 | 0.1 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.0 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.0 | 0.2 | GO:0071709 | membrane assembly(GO:0071709) |
0.0 | 0.0 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.0 | 0.0 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
0.0 | 0.1 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.0 | 0.0 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 0.5 | GO:0006400 | tRNA modification(GO:0006400) |
0.0 | 0.2 | GO:0010939 | regulation of necrotic cell death(GO:0010939) |
0.0 | 0.0 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.0 | 0.4 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.0 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.0 | 0.0 | GO:0061055 | myotome development(GO:0061055) |
0.0 | 0.7 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.0 | GO:0032570 | response to progesterone(GO:0032570) |
0.0 | 0.0 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.0 | 0.2 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.0 | 0.1 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.0 | 0.0 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.0 | 0.0 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.0 | 0.1 | GO:1903019 | negative regulation of glycoprotein metabolic process(GO:1903019) |
0.0 | 0.0 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.0 | 0.0 | GO:0052248 | induction of programmed cell death(GO:0012502) modulation of programmed cell death in other organism(GO:0044531) modulation of apoptotic process in other organism(GO:0044532) positive regulation of apoptotic process in other organism(GO:0044533) modulation by symbiont of host programmed cell death(GO:0052040) positive regulation by symbiont of host programmed cell death(GO:0052042) modulation by symbiont of host apoptotic process(GO:0052150) positive regulation by symbiont of host apoptotic process(GO:0052151) modulation of programmed cell death in other organism involved in symbiotic interaction(GO:0052248) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) modulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052433) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) positive regulation of apoptotic process by virus(GO:0060139) |
0.0 | 0.0 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.0 | 0.0 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.0 | 0.0 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.0 | 0.0 | GO:0010455 | positive regulation of cell fate commitment(GO:0010455) |
0.0 | 0.0 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.0 | 0.1 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.0 | 0.1 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.0 | 0.1 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.0 | 0.2 | GO:0070269 | pyroptosis(GO:0070269) |
0.0 | 0.1 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.0 | 1.2 | GO:0050770 | regulation of axonogenesis(GO:0050770) |
0.0 | 0.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.0 | 0.1 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.0 | 0.0 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.0 | 0.0 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.0 | 0.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.3 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 0.0 | GO:0090427 | activation of meiosis(GO:0090427) |
0.0 | 0.0 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.0 | 0.0 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.0 | 0.1 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.0 | 0.0 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.0 | 0.0 | GO:0015867 | ATP transport(GO:0015867) |
0.0 | 0.0 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.0 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.0 | 0.1 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.5 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.0 | 0.1 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.0 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.0 | 0.0 | GO:0075136 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.0 | 0.0 | GO:0022605 | oogenesis stage(GO:0022605) |
0.0 | 0.0 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.0 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.0 | 0.0 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.0 | 0.0 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.0 | 0.0 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.0 | 0.0 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.0 | 0.0 | GO:0021764 | amygdala development(GO:0021764) |
0.0 | 0.0 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 0.0 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 10.3 | GO:0072534 | perineuronal net(GO:0072534) |
3.0 | 3.0 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
3.0 | 8.9 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
2.8 | 2.8 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
2.7 | 32.2 | GO:0043194 | axon initial segment(GO:0043194) |
2.4 | 11.9 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
2.0 | 10.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
1.9 | 9.6 | GO:0044326 | dendritic spine neck(GO:0044326) |
1.9 | 5.8 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
1.8 | 5.5 | GO:0036396 | MIS complex(GO:0036396) |
1.8 | 12.7 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
1.8 | 88.4 | GO:0042734 | presynaptic membrane(GO:0042734) |
1.8 | 17.8 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
1.7 | 8.5 | GO:0097433 | dense body(GO:0097433) |
1.7 | 29.8 | GO:0030673 | axolemma(GO:0030673) |
1.5 | 7.6 | GO:0061617 | MICOS complex(GO:0061617) |
1.4 | 47.8 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
1.3 | 4.0 | GO:0005608 | laminin-3 complex(GO:0005608) |
1.2 | 4.9 | GO:0033269 | internode region of axon(GO:0033269) |
1.2 | 15.8 | GO:0032433 | filopodium tip(GO:0032433) |
1.2 | 8.4 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
1.2 | 19.0 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
1.2 | 3.6 | GO:1990393 | 3M complex(GO:1990393) |
1.2 | 4.7 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
1.1 | 7.9 | GO:0032584 | growth cone membrane(GO:0032584) |
1.0 | 5.2 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.9 | 3.8 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.9 | 2.8 | GO:0043511 | inhibin complex(GO:0043511) |
0.9 | 4.5 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.9 | 2.6 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.9 | 7.8 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.9 | 2.6 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.8 | 2.5 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.8 | 3.3 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.8 | 15.5 | GO:0043034 | costamere(GO:0043034) |
0.8 | 13.0 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.8 | 11.2 | GO:0043196 | varicosity(GO:0043196) |
0.8 | 5.6 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.8 | 22.2 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.8 | 31.6 | GO:0043198 | dendritic shaft(GO:0043198) |
0.8 | 6.0 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.8 | 4.5 | GO:0043083 | synaptic cleft(GO:0043083) |
0.7 | 8.5 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.7 | 8.3 | GO:0071564 | npBAF complex(GO:0071564) |
0.7 | 1.4 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.7 | 21.9 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.6 | 6.4 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.6 | 1.9 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.6 | 3.1 | GO:0000235 | astral microtubule(GO:0000235) |
0.6 | 4.2 | GO:0030677 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.6 | 0.6 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.6 | 1.8 | GO:0071942 | XPC complex(GO:0071942) |
0.6 | 3.0 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.6 | 2.9 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.6 | 1.7 | GO:0048179 | activin receptor complex(GO:0048179) |
0.5 | 69.4 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.5 | 1.6 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.5 | 2.2 | GO:1990246 | uniplex complex(GO:1990246) |
0.5 | 2.0 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.5 | 3.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.5 | 10.9 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.5 | 2.9 | GO:0031983 | vesicle lumen(GO:0031983) |
0.5 | 14.6 | GO:0032420 | stereocilium(GO:0032420) |
0.5 | 1.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.4 | 26.8 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.4 | 0.9 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.4 | 1.8 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.4 | 1.3 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.4 | 3.8 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.4 | 2.6 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.4 | 3.0 | GO:0033263 | CORVET complex(GO:0033263) |
0.4 | 2.9 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.4 | 1.6 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.4 | 8.5 | GO:0044295 | axonal growth cone(GO:0044295) |
0.4 | 1.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.4 | 8.1 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.4 | 0.4 | GO:0035838 | growing cell tip(GO:0035838) |
0.4 | 3.6 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.4 | 1.4 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.4 | 4.2 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.4 | 4.9 | GO:0000145 | exocyst(GO:0000145) |
0.3 | 1.0 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.3 | 2.1 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.3 | 1.0 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.3 | 5.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.3 | 0.6 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.3 | 0.6 | GO:0030478 | actin cap(GO:0030478) |
0.3 | 3.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.3 | 0.9 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.3 | 5.3 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.3 | 5.8 | GO:0005686 | U2 snRNP(GO:0005686) |
0.3 | 7.5 | GO:0031941 | filamentous actin(GO:0031941) |
0.3 | 7.8 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.3 | 22.5 | GO:0043204 | perikaryon(GO:0043204) |
0.3 | 3.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.3 | 1.1 | GO:0070876 | SOSS complex(GO:0070876) |
0.3 | 1.1 | GO:0033268 | node of Ranvier(GO:0033268) |
0.3 | 29.0 | GO:0030027 | lamellipodium(GO:0030027) |
0.3 | 0.3 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.3 | 1.1 | GO:0060091 | kinocilium(GO:0060091) |
0.3 | 4.1 | GO:0043205 | fibril(GO:0043205) |
0.3 | 3.8 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.3 | 0.8 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.3 | 0.3 | GO:0031523 | Myb complex(GO:0031523) |
0.3 | 2.4 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.3 | 1.5 | GO:0002177 | manchette(GO:0002177) |
0.3 | 1.3 | GO:0071547 | piP-body(GO:0071547) |
0.2 | 2.9 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 29.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 2.4 | GO:0005685 | U1 snRNP(GO:0005685) |
0.2 | 0.5 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 1.4 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.2 | 0.9 | GO:0031045 | dense core granule(GO:0031045) |
0.2 | 2.4 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.2 | 0.9 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.2 | 0.6 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.2 | 1.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.2 | 0.2 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.2 | 2.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 3.7 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 1.2 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.2 | 2.2 | GO:0042555 | MCM complex(GO:0042555) |
0.2 | 1.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.2 | 0.4 | GO:0097441 | basilar dendrite(GO:0097441) |
0.2 | 1.6 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.2 | 0.9 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.2 | 8.5 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.2 | 0.6 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.2 | 0.7 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.2 | 1.8 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.2 | 0.4 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 0.9 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 2.9 | GO:0042588 | zymogen granule(GO:0042588) |
0.2 | 0.3 | GO:0055087 | Ski complex(GO:0055087) |
0.2 | 1.5 | GO:0033391 | chromatoid body(GO:0033391) |
0.2 | 4.3 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.2 | 0.8 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.2 | 1.5 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 2.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.7 | GO:0030658 | transport vesicle membrane(GO:0030658) |
0.1 | 0.3 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.1 | 0.5 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 0.5 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 1.0 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.9 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 0.4 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 0.4 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.5 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 0.6 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.3 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 0.5 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 0.3 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 0.9 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 0.4 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 4.8 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 0.6 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 0.2 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.1 | 0.8 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 0.5 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.1 | 0.8 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 2.1 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 0.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.9 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.7 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 3.1 | GO:0043197 | dendritic spine(GO:0043197) |
0.1 | 0.4 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.4 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 1.4 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.3 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 0.3 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.2 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.1 | 0.4 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 0.2 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 0.3 | GO:0035339 | SPOTS complex(GO:0035339) |
0.1 | 0.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 6.3 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 0.3 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 0.4 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 0.6 | GO:0036156 | inner dynein arm(GO:0036156) |
0.1 | 0.1 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.1 | 0.5 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 0.2 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 0.2 | GO:0035061 | interchromatin granule(GO:0035061) |
0.1 | 0.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 0.1 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.1 | 0.2 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 0.3 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 0.5 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.0 | 0.6 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.0 | 0.1 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.0 | 0.0 | GO:0034705 | potassium channel complex(GO:0034705) |
0.0 | 0.3 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.0 | 0.2 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.0 | 0.2 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.0 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.0 | 0.5 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.1 | GO:0005687 | U4 snRNP(GO:0005687) |
0.0 | 0.1 | GO:0031417 | NatC complex(GO:0031417) |
0.0 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.1 | GO:0071556 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.0 | 0.1 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 0.2 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.0 | 0.2 | GO:0030175 | filopodium(GO:0030175) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
12.7 | 38.1 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
7.1 | 21.3 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
4.4 | 13.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
4.0 | 20.2 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
3.9 | 11.6 | GO:0016842 | amidine-lyase activity(GO:0016842) |
3.6 | 32.3 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
3.6 | 10.7 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
3.5 | 10.4 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
3.0 | 9.0 | GO:0045503 | dynein light chain binding(GO:0045503) |
2.7 | 13.3 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
2.6 | 7.7 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
2.5 | 2.5 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
2.5 | 7.6 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
2.3 | 9.3 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
2.1 | 10.6 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
2.1 | 8.3 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
2.0 | 5.9 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
1.9 | 7.8 | GO:0032051 | clathrin light chain binding(GO:0032051) |
1.9 | 13.5 | GO:0003680 | AT DNA binding(GO:0003680) |
1.8 | 5.4 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.8 | 3.6 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.8 | 5.3 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
1.7 | 8.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.6 | 4.9 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
1.6 | 4.8 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
1.5 | 10.7 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
1.4 | 1.4 | GO:0003896 | DNA primase activity(GO:0003896) |
1.4 | 12.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
1.3 | 2.6 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
1.3 | 28.0 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
1.2 | 10.6 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
1.2 | 12.9 | GO:0070636 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
1.1 | 3.4 | GO:0043495 | protein anchor(GO:0043495) |
1.1 | 10.3 | GO:0039706 | co-receptor binding(GO:0039706) |
1.1 | 19.0 | GO:0016917 | GABA receptor activity(GO:0016917) |
1.1 | 22.3 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
1.1 | 16.6 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
1.1 | 5.5 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
1.1 | 4.4 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.1 | 13.1 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
1.1 | 3.2 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
1.1 | 2.1 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
1.0 | 7.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
1.0 | 4.1 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
1.0 | 9.2 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
1.0 | 7.8 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.0 | 10.7 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.9 | 15.1 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.9 | 3.7 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.9 | 4.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.9 | 2.7 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.9 | 12.9 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.9 | 7.7 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.9 | 17.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.8 | 13.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.8 | 8.3 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.8 | 3.3 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.8 | 2.5 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.8 | 4.0 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.8 | 11.2 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.8 | 4.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.8 | 11.1 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.8 | 2.4 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.8 | 2.4 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.8 | 3.9 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.8 | 2.3 | GO:2001070 | starch binding(GO:2001070) |
0.8 | 2.3 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.8 | 3.0 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.7 | 0.7 | GO:0055100 | adiponectin binding(GO:0055100) |
0.7 | 1.5 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.7 | 2.2 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.7 | 3.6 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.7 | 7.9 | GO:0005522 | profilin binding(GO:0005522) |
0.7 | 2.8 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.7 | 6.3 | GO:0038191 | neuropilin binding(GO:0038191) |
0.7 | 3.4 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.7 | 4.6 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.7 | 1.3 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.7 | 7.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.6 | 2.6 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.6 | 1.9 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.6 | 3.8 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.6 | 0.6 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.6 | 3.2 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.6 | 11.2 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.6 | 3.7 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.6 | 3.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.6 | 13.2 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.6 | 1.8 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.6 | 1.8 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.6 | 12.4 | GO:0052831 | phosphohistidine phosphatase activity(GO:0008969) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) NADP phosphatase activity(GO:0019178) 5-amino-6-(5-phosphoribitylamino)uracil phosphatase activity(GO:0043726) phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) inositol-1,3,4-trisphosphate 1-phosphatase activity(GO:0052829) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) phosphatidylinositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052867) IDP phosphatase activity(GO:1990003) |
0.6 | 2.9 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.6 | 1.7 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.6 | 1.7 | GO:0004359 | glutaminase activity(GO:0004359) |
0.6 | 15.7 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.6 | 17.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.6 | 5.6 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.6 | 2.2 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.5 | 1.6 | GO:0035939 | microsatellite binding(GO:0035939) |
0.5 | 1.6 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.5 | 2.2 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.5 | 2.1 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.5 | 7.5 | GO:0030275 | LRR domain binding(GO:0030275) |
0.5 | 3.7 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.5 | 1.6 | GO:0097016 | L27 domain binding(GO:0097016) |
0.5 | 2.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.5 | 2.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.5 | 2.1 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.5 | 12.5 | GO:0045296 | cadherin binding(GO:0045296) |
0.5 | 1.6 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.5 | 7.2 | GO:0070402 | NADPH binding(GO:0070402) |
0.5 | 1.0 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.5 | 8.6 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.5 | 2.0 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.5 | 3.0 | GO:0031419 | cobalamin binding(GO:0031419) |
0.5 | 4.9 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.5 | 6.4 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.5 | 2.9 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.5 | 1.0 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.5 | 1.0 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.5 | 8.2 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.5 | 0.5 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.5 | 1.9 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.5 | 18.1 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) heparan sulfate 2-O-sulfotransferase activity(GO:0004394) HNK-1 sulfotransferase activity(GO:0016232) heparan sulfate 6-O-sulfotransferase activity(GO:0017095) trans-9R,10R-dihydrodiolphenanthrene sulfotransferase activity(GO:0018721) 1-phenanthrol sulfotransferase activity(GO:0018722) 3-phenanthrol sulfotransferase activity(GO:0018723) 4-phenanthrol sulfotransferase activity(GO:0018724) trans-3,4-dihydrodiolphenanthrene sulfotransferase activity(GO:0018725) 9-phenanthrol sulfotransferase activity(GO:0018726) 2-phenanthrol sulfotransferase activity(GO:0018727) phenanthrol sulfotransferase activity(GO:0019111) 1-hydroxypyrene sulfotransferase activity(GO:0034930) proteoglycan sulfotransferase activity(GO:0050698) cholesterol sulfotransferase activity(GO:0051922) hydroxyjasmonate sulfotransferase activity(GO:0080131) |
0.5 | 4.6 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.5 | 14.1 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.4 | 1.8 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.4 | 2.2 | GO:0070728 | leucine binding(GO:0070728) |
0.4 | 1.3 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.4 | 2.7 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.4 | 2.7 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.4 | 4.9 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.4 | 3.1 | GO:0030957 | Tat protein binding(GO:0030957) |
0.4 | 5.7 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.4 | 3.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.4 | 3.5 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.4 | 0.4 | GO:0034046 | poly(G) binding(GO:0034046) |
0.4 | 5.1 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.4 | 1.3 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.4 | 1.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.4 | 2.5 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.4 | 7.8 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.4 | 1.6 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.4 | 3.7 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.4 | 5.7 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.4 | 1.6 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.4 | 1.6 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.4 | 1.2 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.4 | 1.2 | GO:0019961 | interferon binding(GO:0019961) |
0.4 | 1.9 | GO:0045545 | syndecan binding(GO:0045545) |
0.4 | 2.3 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.4 | 7.8 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.4 | 1.1 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.4 | 2.6 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.4 | 2.2 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.4 | 1.8 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.4 | 3.9 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.4 | 2.1 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.4 | 2.8 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.4 | 2.8 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.4 | 6.3 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.3 | 10.4 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.3 | 2.8 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.3 | 0.3 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.3 | 6.4 | GO:0030332 | cyclin binding(GO:0030332) |
0.3 | 8.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.3 | 2.3 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.3 | 2.3 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.3 | 1.3 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.3 | 1.6 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.3 | 1.0 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.3 | 1.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.3 | 0.9 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.3 | 1.6 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.3 | 0.9 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.3 | 7.5 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.3 | 2.4 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.3 | 3.6 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.3 | 1.8 | GO:0008199 | ferric iron binding(GO:0008199) |
0.3 | 0.6 | GO:0051425 | PTB domain binding(GO:0051425) |
0.3 | 3.8 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.3 | 3.1 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.3 | 0.3 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.3 | 0.3 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.3 | 1.1 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.3 | 0.6 | GO:0046790 | virion binding(GO:0046790) |
0.3 | 2.7 | GO:0001618 | virus receptor activity(GO:0001618) |
0.3 | 0.5 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.3 | 4.3 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.3 | 2.4 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.3 | 0.5 | GO:0009374 | biotin binding(GO:0009374) |
0.3 | 0.8 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.3 | 3.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.3 | 5.1 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 1.5 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.2 | 0.5 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.2 | 3.7 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.2 | 1.5 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 1.0 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 1.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.2 | 3.8 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 0.2 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.2 | 0.7 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.2 | 0.5 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.2 | 0.9 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.2 | 0.5 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.2 | 4.8 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.2 | 1.4 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.2 | 0.7 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.2 | 1.8 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.2 | 0.7 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.2 | 0.9 | GO:0035671 | enone reductase activity(GO:0035671) |
0.2 | 0.4 | GO:0032357 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.2 | 6.1 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.2 | 1.7 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.2 | 0.4 | GO:0050693 | LBD domain binding(GO:0050693) |
0.2 | 0.6 | GO:0016015 | morphogen activity(GO:0016015) |
0.2 | 4.5 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 4.3 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.2 | 0.4 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.2 | 0.8 | GO:1990254 | keratin filament binding(GO:1990254) |
0.2 | 0.6 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.2 | 1.2 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.2 | 1.2 | GO:0030552 | cAMP binding(GO:0030552) |
0.2 | 0.8 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 0.6 | GO:0008142 | oxysterol binding(GO:0008142) |
0.2 | 0.4 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.2 | 2.8 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.2 | 3.8 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.2 | 2.8 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 0.2 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.2 | 3.0 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.2 | 0.7 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.2 | 1.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 1.5 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.2 | 0.9 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.2 | 3.2 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.2 | 0.2 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.2 | 0.4 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.2 | 1.6 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.2 | 0.7 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.2 | 1.0 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.2 | 0.9 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.2 | 0.5 | GO:0034862 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.2 | 0.5 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 0.5 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.2 | 2.4 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.2 | 0.2 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.2 | 0.8 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.2 | 1.0 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.2 | 0.8 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.2 | 0.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 0.7 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.2 | 1.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.2 | 0.6 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.2 | 0.5 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.2 | 0.5 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.2 | 3.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 0.5 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.2 | 0.3 | GO:0034618 | arginine binding(GO:0034618) |
0.2 | 0.3 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 3.0 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 0.4 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.1 | 1.3 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.1 | 0.9 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 1.9 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 1.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.1 | GO:0000701 | purine-specific mismatch base pair DNA N-glycosylase activity(GO:0000701) |
0.1 | 0.6 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.3 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.1 | 0.3 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.1 | 0.7 | GO:0002054 | nucleobase binding(GO:0002054) |
0.1 | 0.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 0.4 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.1 | 0.4 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 1.3 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 0.4 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 4.5 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.1 | 0.4 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.1 | 0.5 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.5 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.5 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.1 | 12.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 1.0 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.1 | 4.1 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 4.9 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
0.1 | 0.4 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.1 | 1.1 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 0.6 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.7 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.5 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.2 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.1 | 0.5 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.1 | 0.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 2.5 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 1.0 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 0.7 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 1.5 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 0.1 | GO:0070990 | snRNP binding(GO:0070990) |
0.1 | 0.7 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 0.1 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.1 | 2.2 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 0.3 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 0.3 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 0.6 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.1 | 0.6 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 4.1 | GO:0015179 | L-amino acid transmembrane transporter activity(GO:0015179) |
0.1 | 0.4 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 50.7 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.1 | 0.3 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 4.4 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 0.9 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.4 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.8 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.5 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.3 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.1 | 1.8 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.1 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.1 | 0.3 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 1.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 1.0 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 4.0 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 0.4 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 13.1 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.1 | 3.1 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 0.9 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.1 | 0.2 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 0.3 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 0.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.2 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.1 | 0.1 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.1 | 0.3 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 0.3 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.1 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.1 | 0.6 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.1 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 1.2 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.4 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 1.6 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.3 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.1 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.1 | 1.5 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 0.6 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.1 | 1.8 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 0.2 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.5 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.1 | 0.1 | GO:0016876 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.1 | 0.2 | GO:0004673 | phosphorelay sensor kinase activity(GO:0000155) protein histidine kinase activity(GO:0004673) |
0.1 | 0.1 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 0.5 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 0.2 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.1 | 0.2 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 0.2 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 0.2 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.2 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.1 | 5.3 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 0.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 1.1 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 2.4 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 0.1 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.1 | 1.3 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.1 | 0.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.3 | GO:0019864 | IgG binding(GO:0019864) |
0.0 | 0.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 0.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 0.1 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.0 | 0.1 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.1 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.0 | 0.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.3 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.9 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.2 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 0.3 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 0.1 | GO:0048185 | activin binding(GO:0048185) |
0.0 | 0.0 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.0 | 0.0 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.5 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 0.4 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.1 | GO:0004103 | choline kinase activity(GO:0004103) |
0.0 | 6.2 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.3 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.0 | 0.1 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.0 | 0.1 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.0 | 0.4 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.0 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.1 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.4 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.1 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.0 | 0.1 | GO:0051734 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.0 | 0.0 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.0 | 0.0 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.0 | 0.1 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.0 | 0.2 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.9 | GO:0044823 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.0 | 0.0 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.0 | 0.0 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.0 | 0.2 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.1 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.0 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.1 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 0.0 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 0.0 | GO:0038100 | nodal binding(GO:0038100) |
0.0 | 0.0 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 2.9 | PID REELIN PATHWAY | Reelin signaling pathway |
1.2 | 18.7 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
1.1 | 2.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.6 | 8.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.6 | 1.7 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.6 | 18.0 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.6 | 8.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.5 | 17.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.5 | 1.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.5 | 6.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.5 | 0.5 | PID IGF1 PATHWAY | IGF1 pathway |
0.5 | 11.7 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.5 | 5.4 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.4 | 4.4 | PID AURORA A PATHWAY | Aurora A signaling |
0.4 | 3.4 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.4 | 0.8 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.4 | 6.7 | PID ARF6 PATHWAY | Arf6 signaling events |
0.3 | 5.2 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.3 | 4.3 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.3 | 4.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.3 | 0.3 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.3 | 3.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 7.7 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 4.7 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 2.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 6.8 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 1.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.2 | 7.9 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 0.9 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.2 | 8.8 | PID ENDOTHELIN PATHWAY | Endothelins |
0.2 | 2.6 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.2 | 3.9 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.2 | 4.7 | PID SHP2 PATHWAY | SHP2 signaling |
0.2 | 1.8 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 0.8 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 4.6 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 0.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 21.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 1.2 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.6 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.1 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 0.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 0.3 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 0.5 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 4.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 3.2 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 0.6 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 0.8 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 0.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 0.4 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 0.3 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 1.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 0.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 0.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 13.5 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.3 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.0 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.0 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.6 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.3 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 56.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
2.3 | 30.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
2.2 | 17.8 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
2.2 | 6.6 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
1.7 | 35.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
1.5 | 31.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
1.4 | 15.9 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
1.3 | 29.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
1.0 | 9.4 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
1.0 | 5.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
1.0 | 14.7 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.9 | 2.8 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.9 | 9.5 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.9 | 19.6 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.8 | 10.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.8 | 11.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.8 | 0.8 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.7 | 2.2 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.7 | 13.8 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.7 | 8.5 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.7 | 5.3 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.6 | 25.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.6 | 6.8 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.6 | 8.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.6 | 4.6 | REACTOME OPSINS | Genes involved in Opsins |
0.6 | 6.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.6 | 2.8 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.5 | 4.9 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.5 | 15.5 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.5 | 11.2 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.5 | 4.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.5 | 4.5 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.5 | 3.9 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.5 | 6.3 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.5 | 18.2 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.5 | 0.5 | REACTOME M G1 TRANSITION | Genes involved in M/G1 Transition |
0.5 | 6.0 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.5 | 1.4 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.4 | 2.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.4 | 4.9 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.4 | 1.7 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.4 | 7.8 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.4 | 2.6 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.4 | 1.8 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.4 | 2.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.3 | 2.8 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.3 | 2.1 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.3 | 5.4 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.3 | 7.2 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.3 | 3.5 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.3 | 4.4 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.3 | 4.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.3 | 3.2 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.2 | 3.7 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.2 | 5.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.2 | 2.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 0.5 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.2 | 0.4 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.2 | 1.3 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.2 | 1.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 1.5 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.2 | 0.4 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.2 | 4.2 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.2 | 1.4 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 1.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 2.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.2 | 1.8 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.2 | 1.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 1.7 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.2 | 0.2 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.2 | 0.5 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.2 | 2.3 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.2 | 0.3 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.2 | 0.6 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 0.6 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 0.9 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.1 | 2.7 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 1.8 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 2.4 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.1 | 1.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 1.6 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 1.4 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 1.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 1.2 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 0.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 2.1 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 1.8 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 2.0 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 0.4 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 0.6 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 0.1 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.1 | 1.8 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 1.5 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.9 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 1.3 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 4.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.5 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.1 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.0 | 0.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 2.0 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.6 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.1 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 0.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.2 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.0 | 0.4 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.0 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.0 | 0.3 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.2 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 0.0 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
0.0 | 2.0 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |